Sequana Medical Nv Stock Profit Margin
| SEQUA Stock | 0.78 0.01 1.27% |
Sequana Medical NV fundamentals help investors to digest information that contributes to Sequana Medical's financial success or failures. It also enables traders to predict the movement of Sequana Stock. The fundamental analysis module provides a way to measure Sequana Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sequana Medical stock.
Sequana |
Sequana Medical NV Company Profit Margin Analysis
Sequana Medical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Sequana Medical NV has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The profit margin for all Belgium stocks is 100.0% lower than that of the firm.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Sequana Fundamentals
| Return On Equity | -2.22 | |||
| Return On Asset | -0.54 | |||
| Current Valuation | 134.46 M | |||
| Shares Outstanding | 23.75 M | |||
| Shares Owned By Insiders | 13.66 % | |||
| Shares Owned By Institutions | 53.97 % | |||
| Price To Book | 11.52 X | |||
| Price To Sales | 182.39 X | |||
| Revenue | 370.5 K | |||
| Gross Profit | 718 K | |||
| EBITDA | (22.24 M) | |||
| Net Income | (23.62 M) | |||
| Total Debt | 7.32 M | |||
| Book Value Per Share | 0.55 X | |||
| Cash Flow From Operations | (23.62 M) | |||
| Earnings Per Share | (1.30) X | |||
| Target Price | 12.0 | |||
| Beta | 0.78 | |||
| Market Capitalization | 134.25 M | |||
| Total Asset | 14.71 M | |||
| Z Score | 7.5 | |||
| Net Asset | 14.71 M |
About Sequana Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sequana Medical NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sequana Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sequana Medical NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Sequana Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sequana Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sequana Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Sequana Stock
The ability to find closely correlated positions to Sequana Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sequana Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sequana Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sequana Medical NV to buy it.
The correlation of Sequana Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sequana Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sequana Medical NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sequana Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Sequana Stock
Sequana Medical financial ratios help investors to determine whether Sequana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sequana with respect to the benefits of owning Sequana Medical security.